The alleged oocyte donation racket reported in Hyderabad has exposed a regulatory problem that extends beyond the fertility centres named in police complaints: safeguards exist on paper, but their protection depends on whether clinics, intermediaries and public authorities follow and enforce them. The cases have also revived questions about how vulnerable women are recruited for egg donation and how prospective parents navigate legal routes for fertility treatment and adoption.
FIRs registered by Begumpet and Saroornagar police name four fertility centres—Padmaja Fertility Centre, Narmada Fertility Centre, Oasis Fertility Centre and Fertilica Fertility. The involvement of the centres remains subject to investigation and independent verification. That qualification is important because the available report establishes the existence of the police cases and the concerns raised by experts, but it does not establish culpability by any of the named centres.
The broader issue is the gap between a regulated medical process and the informal channels that can grow around it. Egg donation is governed by the Assisted Reproductive Technology (Regulation) Act, 2021. The law sets requirements for clinics and banks involved in donor recruitment, medical screening, egg retrieval and the use of donated eggs. These stages are not administrative formalities: they determine who can donate, whether the donor is medically assessed, how the procedure is performed and whether the treatment takes place under professional supervision.
According to fertility specialist Dr Niharika, a woman donating eggs must be between 23 and 35 years old and may donate only once in her lifetime. The process includes medical evaluation, hormonal stimulation and egg retrieval. The report also notes that repeated hormonal stimulation and retrieval can create health risks, including complications associated with anaesthesia. The safeguards therefore address both eligibility and frequency, as well as the clinical conditions in which the procedure is carried out.
The concern raised by the alleged racket is that intermediaries may be recruiting women for commercial egg donation. Experts cited in the report warned that such recruitment could expose vulnerable women to exploitation and raise questions about compliance with the statutory safeguards. The central governance challenge is not simply whether a clinic has a licence or whether a procedure is medically possible. It is whether the complete chain—from recruitment to screening, consent, stimulation, retrieval and record-keeping—is visible to regulators and protected from commercial pressure.
Demand for fertility treatment has grown, according to the experts cited, amid reproductive health conditions and lifestyle factors. The report does not provide a city-level estimate of demand or the number of registered clinics and egg banks in Hyderabad. It does, however, identify the pressure created when people seeking treatment encounter legal and medical systems that may be difficult to understand. Where access is urgent and procedures are complex, intermediaries can acquire influence over both donors and prospective parents.
That makes the distinction between legitimate assistance and improper recruitment especially significant. The supplied report does not establish how the alleged network operated, how women were approached, what payments were involved or whether any clinical procedure breached the law. Those are matters for the police investigation and any subsequent regulatory or judicial process. But the concerns described by experts show why oversight has to cover the full ecosystem rather than only the final medical procedure.
Adoption presents a parallel but distinct institutional challenge. Adoption is governed by the Central Adoption Resource Authority, or CARA, under the Juvenile Justice Act and the Adoption Regulations, 2022. Prospective parents must register on CARA’s CARINGS portal, complete document verification and undergo a home study. A child must be declared legally free for adoption after due inquiry before the adoption process can proceed.
Child Welfare Committee chairman A. Raja Reddy said the process can take years, depending on the availability of children, the seniority of applicants and their preferences. He called for prescribed timelines for each stage, including completion of the home study report after applicants submit the required documents. This points to a different kind of safeguard problem from the one associated with egg donation: adoption requires protection against illegal placement and coercion, but delays and uncertainty can also push prospective parents towards unauthorised channels.
The two systems should not be treated as interchangeable. Assisted reproductive treatment concerns medical procedures, donor eligibility and clinical safety. Adoption concerns the legal status and protection of children, the eligibility of prospective parents and decisions made through a formal child-protection process. Yet both systems involve people who may be vulnerable, time-sensitive decisions and a strong demand for outcomes. Both can therefore be exposed to intermediaries promising faster or easier access outside the prescribed framework.
The institutional responsibilities are spread across different points. Fertility clinics and banks must comply with the ART framework and maintain appropriate medical processes. Police investigate alleged offences and the conduct of individuals or institutions named in complaints. Child Welfare Committees determine whether a child is legally free for adoption after due inquiry. CARA manages the adoption framework and CARINGS registration process. Prospective parents, donors and children encounter the system as individuals, but accountability is divided among these institutions.
That division can make enforcement difficult if information does not move between authorities. The report does not state whether the police cases have resulted in regulatory action, whether any clinic licences have been suspended, or whether the named centres have responded. It also does not identify the number of women or prospective parents allegedly affected. Those gaps prevent a conclusion about the scale of the alleged racket and underline the need to distinguish documented facts from unresolved allegations.
The data available in the report is therefore institutional rather than numerical. It identifies one law governing assisted reproductive technology, one adoption authority, two police stations, four named fertility centres and two sets of procedural safeguards. It also records two time-related limits: an egg donor’s eligibility is restricted to a particular age band and a single donation, while adoption applicants may wait years depending on the system’s available children, applicant seniority and preferences.
These details reveal how differently risk appears in the two systems. In egg donation, the immediate concern is physical exposure and the possibility of repeated or commercially driven procedures. In adoption, the concern is the integrity of the child-protection process and the possibility that delays may encourage people to seek unauthorised alternatives. In both cases, the formal rules are intended to prevent vulnerable people from being treated as inputs in a market for reproductive or family-formation services.
For Hyderabad, the immediate question is what the investigations establish about the alleged recruitment and the role, if any, of the named fertility centres. The longer institutional question is whether existing safeguards can be audited in practice. That includes checking donor eligibility and medical records, tracing the role of intermediaries, ensuring informed consent and determining whether procedures were conducted within the permitted framework. The available report does not say whether such an audit has begun.
The adoption concerns raised alongside the fertility case point to another measurable administrative issue: timelines. Reddy’s call for prescribed deadlines for home-study reports identifies a specific stage at which applicants may face uncertainty. The report does not provide the average waiting period, the number of pending applications or the current staffing and capacity of the relevant authorities. Without those figures, the scale of the delay cannot be assessed, but the procedural bottleneck is clearly identified.
The Hyderabad case thus places two kinds of public oversight in the same frame. One is clinical and regulatory: ensuring that donor recruitment and egg retrieval comply with medical and legal safeguards. The other is administrative and child-centred: ensuring that adoption remains within CARA’s legal process while applications move through verification and home study without avoidable uncertainty. Neither system can be assessed only by the existence of rules; the decisive issue is whether those rules are visible, enforceable and accessible to the people they are meant to protect.
What is established so far is that police cases have been registered, experts have raised concerns about vulnerable women and illegal channels, and the report identifies statutory procedures for both egg donation and adoption. What remains unresolved is the extent of the alleged network, the involvement of the named centres, the number of people affected and the regulatory response. Those facts should emerge through the investigations and any official action that follows.
